Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 3NETWORK 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Osteoporosis 6Prostatic Neoplasms 4Bone Diseases, Metabolic 4Breast Neoplasms 3Triple Negative Breast Neoplasms 1Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteoporosis, Postmenopausal 1Lymphoma 1Lung Neoplasms 1Leukemia 1Dwarfism, Pituitary 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Risedronic Acid × Clear all
NCT00485953 2017-10-13

REBBeCA II

University of Pittsburgh

Phase 4 Completed
109 enrolled 11 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00054418 2016-07-13

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
216 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00859703 2013-10-31

RISAROS

Hospices Civils de Lyon

Phase 3 Completed
20 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡